The Sympathetic Nervous System and Small Artery Neuroeffector Function in Hypertension

Heagerty A M Aalkjaer C. Bund S J Korsgaard N. Mulvany M. J. Small artery structure in hypertension: Dual process of remodeling and growth. Hypertension 1993; 21: 391–97.

Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347–503.

McGregor D. D. The effect of sympathetic nerve stimulation on vasoconstrictor response in perfused mesenteric blood vessels of the rat. J Physiol 1965; 177: 21–30.

Mulvany M J Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19–26.

Laher I. Bevan J. A. Alpha adrenoceptor number limits response of some arteries to norepinephrine. J Pharmacol Exp Ther 1985; 233: 290–97.

Bevan J A Oriowo M A Bevan R. D. Physiological variation in α-adrenoceptor-mediated arterial sensitivity: Relation to agonist affinity. Science 1986; 234: 196–97.

Mulvany M J Aalkjaer C. Christensen J. Changes in noradrenaline sensitivity and morphology of arterial resistance vessels during development of high blood pressure in spontaneously hypertensive rats. Hypertension 1980; 2: 664–67.

Whall C W Myers M M Halpern W. Norepinephrine sensitivity, tension development and neuronal uptake in resistance arteries from spontaneously hypertensive and normotensive rats. Blood Vessels 1980; 17: 1–15.

Nilsson H. Sjoblom N. Folkow B. Neurogenic responses in resistance vessels: Roles of α1- and α2-adrenoceptors, transmitter reuptake, ouabain and plasma factors. J Cardiovasc Pharmacol 1985; 7 (suppl 6): s76–s78.

Mulvany M J Korsgaard N. Nyborg N. Evidence that the increased calcium sensitivity of resistance vessels in spontaneously hypertensive rats is an intrinsic defect in their vascular smooth muscle. Clin Exp Hypertens 1981; 3: 749–61.

Gray S D DeMey J. G. Vascular reactivity in neonatal spontaneously hypertensive rats. Prog Appl Microcirc 1985; 8: 173–80.

Kong J. Taylor D A Fleming W. W. Mesenteric vascular responses of young spontaneously hypertensive rats. J Pharmacol Exp Ther 1991; 258: 13–17.

Webb R C Vanhoutte P. M. Sensitivity to noradrenaline in isolated tail arteries from spontaneously hypertensive rats. Clin Sci Mol Med 1979; 57: 315–35.

Webb R C Vanhoutte P M Bohr D. F. Adrenergic neurotransmission in vascular smooth muscle from spontaneously hypertensive rats. Hypertension 1981; 3: 93–103.

Hermsmeyer K. Electrogenesis of increased norepinephrine sensitivity of arterial vascular muscle in hypertension. Circ Res 1976; 38: 363–67.

Mulvany M J Nilsson H. Nyborg N. Mikkelsen E. Are isolated femoral resistance vessels or tail arteries good models for the hindquarter vasculature of spontaneously hypertensive rats? Acta Physiol Scand 1982; 116: 275–83.

Bund S J West K P Heagerty A. M. Effects of protection from pressure on resistance artery morphology and reactivity in spontaneously hypertensive and Wistar Kyoto rats. Circ Res 1991; 68: 1230–40.

Medgett C. Hicks P E Langer S. Z. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic nerve stimulation to a greater extent in spontaneously hypertensive than Wistar Kyoto rat tail arteries. J Pharmacol Exp Ther 1984; 231: 159–65.

Aqel M B Sharma R V Bhalla R. C. Increased Ca2+ sensitivity of α1-adrenoceptor-stimulated contraction in SHR caudal artery. Am J Physiol 1986; 250: C275–C282.

Laher I. Triggle C. The relationship between elevated blood pressure of the spontaneously hypertensive rat and chemical sensitivity of smooth muscle to adrenergic agents. Can J Physiol Pharmacol 1984; 62: 94–100.

Cassis L A Stitzel R E Head R. J. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: An influence upon neuroeffector mechanisms. J Pharmacol Exp Ther 1985; 234: 792–803.

Nyborg N C B Bevan J. A. Increased α-adrenergic receptor affinity in resistance vessels from hypertensive rats. Hypertension 1988; 11: 635–38.

Bhalla R C Aqel M B Sharma R. V. Alpha1-adrenoceptor mediated responses in vascular smooth muscle of spontaneously hypertensive rats. J Hypertens 1986; 4 (suppl 3): S65–S67.

Nagatsu T. Ikuta K. Numata Y. . Vascular and brain dopamine-β-hydroxylase activity in young spontaneously hypertensive rats. Science 1976; 191: 290.

Nagaoka A. Lovenberg W. Plasma norepinephrine and dopamine-β-hydroxylase in genetic hypertensive rats. Life Sci 1976; 19: 29.

Judy W V Watanabe A M Henry D P Besch H R Murphy W R Hockel G. M. Sympathetic nerve activity: Role in regulation of blood pressure in the spontaneously hypertensive rat. Circ Res 1976; 38 (suppl II): II21–II29.

Judy W V Watanabe A M Murphy W R Aprison B S Yu P. L. Sympathetic nerve activity and blood pressure in normotensive backcross rats genetically related to the spontaneously hypertensive rat. Hypertension 1979; 1: 598–604.

Johnson E M O'Brien F. Evaluation of the permanent sympathectomy produced by the administration of guanethidine to adult rats. J Pharmacol Exp Ther 1976; 196: 53.

Johnson E M O'Brien F. Werbitt R. Modification and characterisation of the permanent sympathectomy produced by the administration of guanethidine to newborn rats. Eur J Pharmacol 1976; 37: 45.

Lee R. M. K. W. Structural and functional consequences of anti-hypertensive treatments on blood vessels. In: Lee R M K W ed. Blood vessel changes in hypertension: Structure and function, Volume II. Boca Raton, FL: CRC Press, 1989.

Levi-Montalcini R. Booker B. Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve growth protein. Proc Natl Acad Sci USA 1960; 46: 384–91.

Goedert M. Otten U. Thoenen H. Biochemical effects of antibodies against nerve growth factor on developing and differentiated sympathetic ganglia. Brain Res 1978; 148: 264–68.

Levi-Montalcin R. Calissano P. The nerve growth factor. Sci Am 1979; 240: 68–77.

Korsching S. Thoenen J. Nerve growth factor in sympathetic ganglia and corresponding target organ of the rat: Correlation with density of sympathetic innervation. Proc Natl Acad Sci USA 1983; 80: 3513–16.

Korsching S. Thoenen H. Quantitative demonstration of the retrograde axonal transport of endogenous nerve growth factor. Neurosci Lett 1983; 39: 1–4.

Shelton D L Reichardt L. F. Expression of β-nerve growth factor gene correlates with the density of sympathetic innervation in effector organs. Proc Natl Acad Sci USA 1984; 81: 7915–55.

Heumann R. Korsching S. Scott J. Thoenen H. Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. EMBO J 1984; 3: 3183–89.

Donohue S J Head R J Stitzel R. E. Elevated nerve growth factor levels in young spontaneously hypertensive rats. Hypertension 1989; 14: 421–26.

Falckh P H Harkin L A Head R. J. Resistance vessel gene expression of nerve growth factor is elevated in young spontaneously hypertensive rats. J Hypertens 1992; 10: 913–18.

Folkow B. Hallback M. Lundgren Y. Weiss L. The effects of ‘immunosympathectomy’ on blood pressure and vascular ‘reactivity’ in normal and spontaneously hypertensive rats. Acta Physiol Scand 1972; 84: 512.

Cutilletta A F Erinoff L. Heller A. Low J. Oparil S. Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy. Circ Res 1977; 40: 428–34.

Page E. Oparil S. Effect of peripheral sympathectomy on left ventricular ultrastructure in young spontaneously hypertensive rats. J Mol Cell Cardiol 1978; 10: 301–305.

Johnson E M Macia R. A. Unique resistance to guanethidine-induced chemical sympathectomy of spontaneously hypertensive rats. A resistance overcome by antibody to nerve growth factor. Circ Res 1979; 45: 243.

Cutilletta A F Oparil S. Hemodynamic response to vascular expansion following immunosympathectomy in spontaneously hypertensive rats. Hypertension 1980; 2: 304–10.

Lee R M K W Triggle C R Cheung D N T Coughlin M. D. Structural and functional consequences of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension 1987; 10: 328–38.

Head R. J. Hypernoradrenergic innervation: Its relation to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 1989; 26: 1–20.

Berkowitz B A Spector S. Uptake, storage and synthesis of catecholamines in blood vessels and its significance to vascular function and drug action. In: Bevan J A Burnstock G. Johansson O. Maxwell R A eds. Vascular neuroeffector mechanisms, 2nd International Symposium. Basel: Karger, 1976.

Head R J Berkowitz B. A. Vascular circulating catecholamines in diabetes and hypertension. In: Usdin E. Kopin I J Barchas J D eds. Catecholamines, basis and clinical frontiers. New York: Pergamon Press, 1979.

Berkowitz B A Hempstead J. Hahn R. Vascular catecholamines, hypertension and stress. In: Usdin E. Kvetnansky R. Kopin I J eds. Catecholamines and stress: Recent advances. North-Holland, Amsterdam: Elsevier, 1980.

Head R J Cassis L A Barone S. Stitzel R E De la Lande I. S. Neuronal deamination of endogenous and exogenous noradrenaline in the mesenteric artery of the spontaneously hypertensive rat. J Pharm Pharmacol 1984; 36: 382–85.

Head R J Cassis L A Robinson R L Westfall D P Stitzel R. E. Altered catecholamine contents in vascular and nonvascular tissues in genetically hypertensive rats. Blood Vessels 1985; 22: 196–204.

Hano T. Rho J. Norepinephrine overflow in perfused mesenteric arteries of spontaneously hypertensive rats. Hypertension 1989; 14: 44–53.

Donohue S J Stitzel R E Head R. J. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats. J Pharmacol Exp Ther 1988; 245: 24–31.

Yamamoto R. Cline W. H. Effects of propranolol and yohimbine on periarterial nerve stimulation-induced release of endogenous norepinephrine from the mesenteric vasculature of Wistar Kyoto and spontaneously hypertensive rats. J Pharmacol Exp Ther 1987; 244: 905–11.

Scott T M Pang S. C. The correlation between the development of sympathetic innervation and the development of medial hypertrophy in jejunal arteries in normotensive and spontaneously hypertensive rats. J Auton Nerv Syst 1983; 8: 25–32.

Lee R M K W Garfield R E Forrest J B Daniel E. E. Morphometric study of structural changes in the mesenteric blood vessels of spontaneously hypertensive rats. Blood Vessels 1983; 20: 57–71.

Lee R. M. K. W. Vascular changes at the prehypertensive phase in the mesenteric arteries from spontaneously hypertensive rats. Blood Vessels 1985; 22: 105–26.

Featherstone M A McGregor D D Phelan E. L. Differences in the density of sympathetic vascular innervations in New Zealand genetically hypertensive (GH) rats and Japanese spontaneously hypertensive rats (SHR). Proc Univ Otago Med School 1984; 62: 25–26.

Mangiarua E I Lee R. M. K. W. Increased sympathetic innervation in the cerebral and mesenteric arteries of hypertensive rats. Can J Physiol Pharmacol 1990; 68: 492–99.

Kawamura K. Ando K. Takebayashi S. Perivascular innervation of mesenteric artery in spontaneously hypertensive rats. Hypertension 1989; 14: 660–65.

Fouda A. Marazzi A. Boillat N. Sonnay M. Guillain H. Atkinson J. Changes in the vascular reactivity of the isolated tail arteries of spontaneous and renovascular hypertensive rats to endogenous and exogenous noadrenaline. Blood Vessels 1987; 24: 63–75.

Galloway M P Westfall T. C. The release of endogenous norepinephrine from the coccygeal artery of spontaneously hypertensive and Wistar-Kyoto rats. Circ Res 1982; 51: 225–32.

Bevan R D Tsuru H. Long-term denervation of vascular smooth muscle causes not only functional but structural change. Blood Vesseb 1979; 16: 109–12.

Rusterholz D B Mueller S. M. Sympathetic nerves exert a chronic influence on the intact vasculature that is age related. Ann Neurol 1982; 11: 365–71.

Owens G. K. Differential effects of anti-hypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy and hyperplasia in the spontaneously hypertensive rat. Circ Res 1985; 56: 525–36.

Chamley J H Cambell G. R. Tissue culture: Interaction between sympathetic nerves and vascular smooth muscle. Proc 2nd Int Symp Vascular Neuroeffector Mechanisms, Odense, 1976.

Southwell B B Cambell Chamley J H Cambell G. R. Trophic interactions between sympathetic nerves and vascular smooth muscle. J Auton Nerv Syst 1985; 13: 343–54.

Tsuda K. Kusuyama Y. Hano T. Kuchii M. Nishio I. Masuyama Y. Alteration of presynaptic α2-mediated inhibition of norepinephrine release in perfused mesenteric arteries of young and adult spontaneously hypertensive rats. J Hypertens 1984; 2 (suppl 3): 95–97.

Tsuda K. Kuchii M. Nishio I. Masuyama Y. Effects of epinephrine and dopamine on norepinephrine release from sympathetic nerve endings in hypertension. J Hypertens 1986; 4 (suppl 5): S45–S48.

Tsuda K. Tsuda S. Masuyama Y. Enhanced neuroinhibitory effect of diltiazem in blood vessels of spontaneously hypertensive rats. Am J Hypertens 1990; 3: 555–59.

Tsuda K. Masuyama Y. The role of protein kinase C and calcium in the regulation of norepinephrine release from the vascular adrenergic neurons in hypertension. Am J Hypertens 1990; 3: 879–82.

Tsuda K. Masuyama Y. Effects of substance P on norepinephrine release from vascular adrenergic neurons in spontaneously hypertensive rats Am J Hypertens 1991; 4: 327–32.

Masuyama Y. Tsuda K. Kuchii M. Nishio I. Peripheral neural mechanisms of hypertension in rat models – peripheral sympathetic neurotransmission in hypertension. J Hypertens 1986; 4 (suppl 3): S189–92.

Yamamoto R. Cline W. H. Release of endogenous NE from the mesenteric vasculature of WKY and SHR in response to PNS. J Pharmacol Exp Ther 1987; 241: 826–32.

Takata Y. Mochizuki S. Kato H. Effect of chronically administered hydralazine on altered adrenergic neurotransmission mediated by presynaptic α- and β-adrenoceptors in spontaneously hypertensive rats. J Pharmacobio-Dyn 1990; 13: 565–73.

Muir T C Wardle K. A. Vascular smooth muscle responses in normo- and hypertensive rats to sympathetic nerve stimulation and putative transmitters. J Auton Pharmacol 1989; 9: 23–34.

Westfall T C Carpentier S. Naes L. Meldrum M. J. Comparison of norepinephrine release in hypertensive rats: II. Caudal artery and portal vein. Clin Exp Hypertens – Theory Pract 1986; A8: 221–37.

Luthin D R Cline W. H. Evidence for enhanced inhibitory modulation by cyclooxygenase products of noradrenergic neurotransmission in the mesenteric vasculature of young spontaneously hypertensive rats. J Pharmacol Exp Ther 1991; 259: 1174–81.

Jackson E. K. Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats. Am J Physiol 1987; 253: H909–H918.

Stephens N. Bund S J Jagger C. Heagerty A. M. Arterial neuroeffector responses in early and mature spontaneously hypertensive rats. Hypertension 1991; 18: 674–82.

Tsuji T. Su C. Lee T. J. F. Enhanced presynaptic β2-adrenoceptor-mediated facilitation of the pressor response in the prehypertensive SHR. J Cardiovasc Pharmacol 1989; 14: 737–46.

Nilsson H. Folkow B. Vasoconstrictor nerve influence on isolated mesenteric resistance vessels from normotensive and hypertensive rats. Acta Physiol Scand 1982; 116: 205–208.

Nilsson H. Sjoblom N. Extent of α2-receptor-mediated autoinhibition of vasoconstrictor nerve responses in mesenteric resistance vessels from normotensive and hypertensive rats. J Hypertens 1984; 2 (suppl 3): 103–105.

Triggle C R Laher I. A review of changes in vascular smooth muscle functions in hypertension: Isolated tissue versus in vivo studies. Can J Physiol Pharmacol 1985; 63: 355–65.

Rapp J. P. A paradigm for identification of primary genetic causes of hypertension in rats. Hypertension 1983; vmr-5 (suppl 1): 1198–1203.

Mulvany M. J. Resistance vessel structure and function in the etiology of hypertension studied in F2-generation hypertensive-normotensive rats. J Hypertens 1988; 6: 655–63.

Langer S. Z. Presynaptic regulation of catecholamine release. Biochem Pharmacol 1974; 23: 1793–800.

Langer S. Z. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 1977; 60: 481–97.

Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol Rev 1980; 32: 337–62.

Starke K. Presynaptic α-autoreceptors. Rev Physiol Biochem Pharmacol 1987; 107: 73–146.

Starke K. Borowski E. Endo T. Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 1975; 34: 385–88.

Ekas R D Lokhandwala M. F. Sympathetic nerve function and vascular reactivity in spontaneously hypertensive rats. Am J Physiol 1981; 241: R379–R384.

Westfall T C Meldrum M J Badino L. Earnhardt J. T. Noradrenergic transmission in the isolated portal vein of the spontaneously hypertensive rat. Hypertension 1984; 6: 267–74.

Crews F T Smith C. B. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration. J Pharmacol Exp Ther 1980; 215: 143–49.

Smith C B Garcia-Sevilla J A Hollingsworth P. J. Alpha2-adrenoceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment. Brain Res 1982; 210: 413–18.

Salles J. Badia A. Modulation of α1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake. Br J Pharmacol 1993; 108: 678–83.

Alder E. Langer S. Z. Possible role of a β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feedback mechanism. Br J Pharmacol 1975; 53: 43–50.

Stjarne L. Brundin J. β2-Adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves. Acta Physiol Scand 1976; 97: 88–93.

Kawasaki H. Cline W H Su C. Involvement of the renin-angiotensin system in β-adrenoceptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats. J Pharmacol Exp Ther 1984; 231: 23–32.

Dahlof C. Studies on beta-adrenoceptor mediated facilitation of sympathetic neurotransmission. Acta Physiol Scand 1981; 500 (suppl): 1–147.

Majewski H. Modulation of norepinephrine release through activation of presynaptic β-adrenoceptors. J Auton Pharmacol 1983; 3: 47–60.

Heimburger M. Montero M J Fougeres V. . Presynaptic beta-adrenoceptors in rat atria: Evidence for the presence of stereoselective beta1-adrenoceptors. Br J Pharmacol 1989; 98: 211–17.

Nedergaard O A Abrahamsen J. Modulation of noradrenaline release by activation of presynaptic β-adrenoceptors in the cardiovascular system. Ann NY Acad Sci 1990; 604: 528–44.

Osswald W. Guimaraes S. Adrenergic mechanisms in blood vessels: Morphological and pharmacological aspects. Rev Physiol Biochem Pharmacol 1983; 96: 81–85.

Lands A M Arnold A. McAuliff J P Luduena F P Brown T. G. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967; 214: 597–98.

Dahlof C. Ljung B. Ablad B. Increased noradrenaline release in rat portal vein during sympathetic nerve stimulation due to activation of presynaptic adrenoceptors by noradrenaline and adrenaline. Eur J Pharmacol 1978; 50: 75–78.

Majewski H. Rand H J Tung L. H. Activation of prejunctional β-adrenoceptors in rat atria by adrenaline applied exogenously or released as a cotransmitter. Br J Pharmacol 1981; 73; 669–79.

Berecek K H Brody M. J. Evidence for a neurotransmitter role for epinephrine derived from the adrenal medulla. Am J Physiol 1982; 242: H593–H601.

Rand M J Majewski H. McCulloch M W Story D. F. An adrenaline-mediated positive feedback loop in sympathetic transmission and its possible role in hypertension. In: Langer S Z Stark K. Dubocovich M L eds. Advances in the biosciences: Presynaptic receptors, Volume 18. Oxford: Pergamon Press, 1979: 263–69.

Vlachakis N D Alexander N. Maronde R. H. Increased plasma normetanephrine in spontaneously hypertensive rats. Clin Exp Hypertens 1980; 2: 309–19.

Pak C. H. Plasma adrenaline and noradrenaline concentrations in the spontaneously hypertensive rat. Jpn Heart J 1981; 22: 987–95.

Grobecker H. Saavedra J M Weise V. K. Biosynthetic enzyme activities and catecholamines in adrenal glands of genetic and experimental hypertensive rats. Circ Res 1982; 50: 742–46.

Majewski H. Tung L H Rand M. J. Adrenaline-induced hypertension in rats. J Cardiovasc Pharmacol 1981; 3: 179.

Majewski H. Tung L H Rand M. J. Adrenaline activation of prejunctional β-adrenoceptors and hypertension. J Cardiovasc Pharmacol 1982; 4: 99.

Borkowski K R Quinn P. The effect of bilateral adrenal demedullation on vascular reactivity and blood pressure in spontaneously hypertensive rats. Br J Pharmacol 1983; 80: 429–37.

Borkowski K R Quinn P. Adrenaline and the development of spontaneous hypertension in rats. J Auton Pharmacol 1985; vmr-5: 89–100.

Borkowski K. R. The effect of adrenal demedullation and adrenaline on hypertension development and vascular reactivity in young spontaneously hypertensive rats. J Auton Pharmacol 1991; 11: 1–14.

Borkowski K R Quinn P. Beta2-adrenoceptors mediate adrenaline's facilitation of neurogenic vasoconstriction. Eur J Pharmacol 1984; 103: 339–42.

Kawasaki H. Cline W H Su C. Enhanced presynaptic beta adrenoceptor mediated modulation of vascular adrenergic neurotransmission in spontaneously hypertensive rats. J Pharmacol Exp Ther 1982; 223: 721–28.

Doyle A E Frazer J R E Marshall R. J. Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. Clin Sci 1959; 18: 441–53.

Sivertsson R. Olander R. Aspects of the nature of the increased vascular resistance and increased ‘reactivity’ to noradrenaline in hypertensive subjects. Life Sci 1968; 7: 1291–97.

Jie K. Van Brummelen P. Vermey J P Timmermans P B M W M Van Zwieten P. A. α1- and α2-adrenoceptor mediated vasoconstriction in the forearm of normotensive and hypertensive subjects. J Cardiovasc Pharmacol 1986; 8: 190–96.

Amann F W Bolli P. Buhler F. R. Enhanced alpha-adrenoceptor-mediated vasoconstriction in essential hypertension. Hypertension 1981; 3 (suppl I): I119–I123.

Egan B. Panis R. Hinderliter A. Schork N. Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987; 80: 812–17.

Kiowski W. Van Brummelen P. Buhler F. R. Plasma noradrenaline correlates with α-adrenoceptor-mediated vasoconstriction and blood pressure in patients with essential hypertension. Clin Sci 1979; 57: 177s–180s.

Eichler H G Ford G A Blaschke T F Swislocki A. Hoffman B. B. Responsiveness of superficial hand veins to phenylephrine in essential hypertension: Alpha adrenergic blockade during prazosin therapy J Clin Invest 1989; 83: 108–12.

Horwitz D. Clineschmidt B V Vanburen J M Ommaya A. K. Temporal arteries from hypertensive and normotensive man. Circ Res 1974; 34/35 (suppl 1): I109–I115.

Moulds R. F. W. Reduced responses to noradrenaline of isolated digital arteries from hypertensives. Clin Exp Pharmacol Physiol 1980; 7: 505–508.

Thulesius O. Gjores J E Berlin E. Vascular reactivity of normotensive and hypertensive human arteries. Gen Pharmacol 1983; 14: 153–54.

Wyse D. G. Relationship of blood pressure to the responsiveness of an isolated human artery selected agonists and electrical stimulation. J Cardiovasc Pharmacol 1984; 6: 1083–91.

Aalkjaer C. Heagerty A M Petersen K K Swales J D Mulvany M. J. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation–contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61: 181–86.

Nielsen H. Thom SMcG Hughes A D Martin G N Mulvany M J Sever P. S. Postjunctional α2-adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels. Br J Pharmacol 1989; 97: 829–34.

Nielsen H. Mortensen F V Mulvany M. J. Responses to noradrenaline in human subcutaneous resistance arteries are mediated by both α1- and α2-adrenoceptors. Br J Pharmacol 1990; 99: 31–34.

Jie K. Van Brummelen P. Vermey P. Timmermans P B M W M Van Zwieten P. A. Differences between exogenous and endogenous noradrenaline in the effects of vascular postsynaptic α1- and α2-adrenoceptors in man. J Hypertens 1985; 3 (suppl 3): S145–S147.

Jie K. Van Brummelen P. Vermey P. Timmermans P B M W M Van Zwieten P. A. Postsynaptic α1- and α2-adrenoceptors in human blood vessels: Interactions with exogenous and endogenous catecholamines. Eur J Clin Invest 1987; 17: 174–81.

Stephens N. Bund S J Faragher E B Heagerty A. M. Neurotransmission in human resistance arteries: Contribution of α1 and α2-adrenoceptors but not P2-purinoceptors. J Vasc Res 1992; 29: 347–52.

Parkinson N A Thom S A Hughes A D Sever P S Mulvany M J Nielsen H. Neurally evoked responses of isolated human resistance arteries are mediated by both α1- and α2-adrenoceptors. Br J Pharmacol 1992; 106: 568–73.

Lund-Johansen P. Hemodynamics in early essential hypertension. Acta Med Scand 1967; 482 (suppl): 1–105.

Julius S. Conway J. Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 1968; 38: 282–88.

Frolich E D Kozul V J Tarazi R C Dustan H. P. Physiological comparison of labile and essential hypertension. Circ Res 1970; 26 (suppl I): 55–69.

Julius S. Pascual A. Sannerstedt R. Mitchell C. Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 1971; 43: 382–90.

Esler M. Julius S. Zweifter A. . Mild high-renin essential hypertension: A neurogenic human hypertension. N Engl J Med 1977; 296: 405–11.

Julius S. Petrin J. Autonomic nervous and behavioral factors in hypertension: A rationale for treatment. In: Laragh J H Brenner B M eds. Hypertension: Pathophysiology, diagnosis and management. New York: Raven Press, 1990.

Brown G L Gillespie J. S. The output of sympathetic transmitter from the cat spleen. J Physiol 1957; 138: 81–102.

Yamaguchi N. De Champlain J. Nadeau R. A. Correlation between the response of the heart to sympathetic stimulation and the release of endogenous catecholamines into the coronary sinus of the dog. Circ Res 1975; 36: 662–68.

Brown M J Allison D J Jenner D A Lewis P J Dollery C. T. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet 1981; 1: 174–77.

Planz G. Planz R. Dopamine β-hydroxylase, adrenaline, noradrenaline, and dopamine in the venous blood of adrenal gland in man: A comparison with levels in the periphery of the circulation. Experientia 1979; 35: 207–208.

Esler M. Jennings G. Leonard P. . Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand 1984; 527 (suppl): 11–16.

Ziegler M G Lake C R Wood J H Brook B R Ebert M. H. Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood–cerebrospinal barrier for norepinephrine. J Neurochem 1977; 28: 677–79.

Eide I. Kolloch R. De Quattro V. Miano L. Dugger R. Van der Meulen J. Raised cerebrospinal fluid norepinephrine in patients with primary hypertension. Hypertension 1979; 1: 225–60.

Hoeldtke R D Rogawski M. Wurtman R. J. Effect of selective destruction of central and peripheral catecholamine containing neurons with 6-hydroxy dopamine on catecholamine excretion in the rat. Br J Pharmacol 1974; 50: 265–70.

Goldstein D. S. Plasma catecholamines and essential hypertension: An analytical review. Hypertension 1983; vmr-5: 86–99.

Esler M. Jennings G. Biviano B. Lambert G. Hasking G. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 1986; 8 (suppl 5): S39–S43.

Goldstein D S Lake C R Chernow B. . Age-dependence of hypertensive–normotensive differences in plasma norepinephrine. Hypertension 1983; vmr-5: 100–104.

Esler M. Jennings G. Korner P. . Assessment of human sympathetic nervous activity from measurements of norepinephrine turnover. Hypertension 1988; 11: 3–20.

Esler M. Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. Clin Sci 1982; 62: 247–54.

Esler M. Jackman G. Bobik A. . Norepinephrine kinetics in essential hypertension: Defective neuronal uptake of norepinephrine in some patients. Hypertension 1981; 3: 149–56.

Goldstein D S Horwitz D. Keiser H R Polinsky R J Kopin I. J. Plasma 1-[3H]norepinephrine d-[14C]norepinephrine and d-[3H]isoproterenol kinetics in essential hypertension. J Clin Invest 1983; 72: 1748–58.

Esler M. Jackman G. Leonard P. . Determination of noradrenaline uptake, spillover to plasma and plasma concentrations in patients with essential hypertension. Clin Sci 1980; 59: 311s–313s.

Hagbarth K E Vallbo A. B. Pulse and respiratory grouping of sympathetic impulses in human muscle nerves. Acta Physiol Scand 1968; 74: 96–108.

Wallin B G Delius W. Hagbarth K. Comparison of sympathetic nerve activity in normotensive and hypertensive subjects. Circ Res 1973; 33: 9–21.

Wallin B G Sundlof G. A quantitative study of muscle nerve sympathetic activity in resting normotensive and hypertensive subjects. Hypertension 1979; 1: 67–77.

Morlin C. Wallin B G Eriksson B. M. Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man. Acta Physiol Scand 1983; 119: 117–21.

Anderson E A Sinkey C A Lawton W J Mark A. L. Elevated sympathetic nerve activity in borderline hypertensive humans: Evidence from direct intraneural recordings. Hypertension 1989; 14: 177–83.

Yamada Y. Miyajima E. Tochikubo O. Matsukawa T. Ishii M. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 1989; 13: 870–77.

Aalkjaer C. Heagerty A M Bailey I. Mulvany M J Swales J. D. Studies of isolated resistance vessels from offspring of essential hypertensive patients. Hypertension 1987; 9 (suppl III): III-155–III-158.

Hallin R G Torebjork H. E. Single unit sympathetic nerve activity in human skin nerves during rest and various manoeuvres. Acta Physiol Scand 1974; 92: 303–17.

Nezu M. Miura Y. Adachi M. . The effects of epinephrine on noradrenaline release in essential hypertension. Hypertension 1985; 7: 187–95.

Blankestijn P J In't Veld Man A J Tulen J. . Support for adrenaline-hypertension hypothesis: 18 hour pressor effects after 6 hours adrenaline infusion. Lancet 1988; 2: 1386–89.

Floras J S Aylward D E Victor R G Mark A L Abboud F. M. Epinephrine facilitates neurogenic vasoconstriction in humans. J Clin Invest 1988; 81: 1265–74.

Floras J S Sole M J Morris B. L. Desipramine blocks augmented neurogenic vasoconstriction to epinephrine. Hypertension 1990; 15: 132–39.

Vincent H H In't Veld Man A J Boomsma F. Wenting G J Schalekamp M. A. D. H. Elevated plasma noradrenaline in response to β-adrenoceptor stimulation in man. Br J Clin Pharmacol 1982; 13: 717–21.

Ferrier C. Esler M D Eisenhofer B. . Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension 1992; 19: 62–69.